COMP <GO>
FOCL vs ABBV // ENTERPRISE SCALE & MARKET CAP
EDAP TMS S.A. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: FOCL 0
— ABBV 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ABBV
LAST: $4.17 (-2.11%) • MKT CAP: $191.6M
market-cap
$191.6M
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
market-cap
$513.86B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FOCL VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FOCL | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.50% | 70.20% | -27.70 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 29.00% | -64.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.56% | 3.47% | -12.03 | ABBV | /fcf-yield <GO> |
| Operating Margin | -35.00% | 24.60% | -59.60 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -41.50% | 6.90% | -48.40 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 1.60% | 8.60% | -7.00 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.33 | -5.13 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.6 | 65.1 | -17.51 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $191.6M | $513.86B | -$513.67B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FOCL REV | ABBV REV | FOCL GROSS % | ABBV GROSS % | FOCL FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $70.5M | $61.16B | 42.5% | 70.2% | -$16.4M | $17.82B |
| FY 2024 | $69.4M | $56.33B | 41.4% | 70.0% | -$14.7M | $17.83B |
| FY 2023 | — | $54.32B | — | — | — | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FOCL // BETA —
ABBV // BETA 1.15